BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

8305	Companies
115220	Keywords
55528	Articles
62574	Press releases

Home
Companies
BIOMERIEUX

BRIEF

published on 05/06/2024 at 17:23, 6 months 15 days ago

Mise à jour financière de bioMérieux : Aperçu du capital social et des droits de vote en avril 2024

Droits De Vote Capital Social BioMérieux Actions Diagnostic In Vitro
BRIEF

published on 05/06/2024 at 17:23, 6 months 15 days ago

BioMérieux financial update: Overview of share capital and voting rights in April 2024

Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
REGULATED PRESS RELEASE

published on 05/06/2024 at 17:18, 6 months 15 days ago

Avril 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Communiqué de presse mensuel de bioMérieux concernant le nombre total de droits de vote et d'actions, conformément aux réglementations financières en vigueur

Autorité Des Marchés Financiers BioMérieux Nombre De Droits De Vote Règlement Général Informations Mensuelles
BRIEF

published on 04/09/2024 at 07:20, 7 months 13 days ago

BioMérieux dévoile GO•28, son plan stratégique quinquennal

BioMérieux Diagnostic In Vitro Croissance Organique RSE GO•28
BRIEF

published on 04/09/2024 at 07:20, 7 months 13 days ago

BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan

Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:15, 7 months 13 days ago

bioMérieux présente son nouveau plan stratégique à 5 ans et son objectif de croissance rentable
bioMérieux présente son nouveau plan stratégique GO•28 visant une croissance rentable et durable pour les 5 prochaines années

BioMérieux Plan Stratégique Diagnostic In Vitro Croissance Rentable GO•28
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:15, 7 months 13 days ago

bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030

BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
BRIEF

published on 04/09/2024 at 07:06, 7 months 13 days ago

BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth

BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
BRIEF

published on 04/09/2024 at 07:06, 7 months 13 days ago

BioMérieux annonce une croissance robuste au premier trimestre 2024

BioMérieux Diagnostic In Vitro Croissance Des Ventes BIOFIRE SPOTFIRE
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:01, 7 months 13 days ago

bioMérieux – First-Quarter 2024 Business Review
bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit

BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology

Accesswire

Published on 11/22/2024 at 09:00, 2 hours 52 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 11 hours 52 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 13 hours 47 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 2 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 15 hours 37 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 11:45, 7 minutes ago

How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 31 minutes ago

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 46 minutes ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/22/2024 at 11:00, 52 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 10:46, 1 hour 6 minutes ago

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

Les Echos

Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 15 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 16 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE